Harnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles
Molecular Therapy2012Vol. 20(8), pp. 1582–1589
Citations Over TimeTop 10% of 2012 papers
Tomoko Nakayama, James S. Butler, Alfica Sehgal, Mariano Severgnini, Tim Racie, Jennifer Sharman, Feng Ding, Svetlana Shulga Morskaya, Joshua Brodsky, Lubomir Tchangov, Verbena Kosovrasti, M Meys, Lubomir V. Nechev, Gang Wang, Chang G. Peng, Yupang Fang, Martin A. Maier, Kallanthottathil G. Rajeev, Robert Li, Julia Hettinger, Scott Barros, Valerie A. Clausen, Xuemei Zhang, Qianfan Wang, Renta Hutabarat, Nikolay V. Dokholyan, Christian Wolfrum, Muthiah Manoharan, Victor Kotelianski, Markus Stoffel, Dinah W.Y. Sah
Related Papers
- → Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells(2004)378 cited
- → Lipoprotein Heterogeneity and its Effect on Apolipoprotein Assays(1990)11 cited
- → Short Interfering RNA (siRNA)—Mediated RNA Interference (RNAi) in Human Cells(2003)82 cited
- → Can siRNA Technology Provide the Tools for Gene Therapy of the Future?(2006)34 cited
- → Apolipoprotein A-1 and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP)(1992)9 cited